Chronic kidney disease: open trials in Tunisia

3 open trials have a site in Tunisia. Registry data; only the trial team decides who can take part.

NCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hopital Regional Mohamed Tahar Al Maamouri, Nabeul · Hopital Habib Thameur, Tunis
Registry updated 2026-11-04
NCT07906405
Malnutrition and Sarcopenia in Adults With Chronic Kidney Disease in Tunisia
Research · Dacima Consulting
Hôpital Militaire Principal d'Instruction de Tunis, Department of Nephrology, Tunis
Registry updated 2026-10-30
NCT07688434
Pilot Trial of Oral Sodium Bicarbonate Versus Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis
Trial Treatment · University of Sfax
Social security fund polyclinic, Sfax
Registry updated 2026-07-21

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)